Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
- PMID: 31720171
- PMCID: PMC6823008
- DOI: 10.7759/cureus.5703
Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
Abstract
Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the 'clinical benefit score' (CBS), utilized as a method for treatment prioritization for PBT operating in a 'cost-neutral' proton-photon payer environment. Materials & methods This study includes patients considered for PBT at a center that initially had only one or two treatment rooms available for clinical use. Patients were prospectively scored using the CBS, and higher scores were prioritized. The outcome was receipt of PBT and the independent variable was CBS. Crude and adjusted analyses were performed using logistic regression. Results There were 2163 patients evaluated. A total of 205 patients (9.5%) were deemed candidates for PBT, which was received by 122 (5.6%) patients. In patients considered for PBT, the mean CBS was 18.7. Patients who were <21 years old, female, non-Caucasian, receiving re-irradiation, and those with Medicare had a higher CBS. Multivariate analysis adjusting for insurance status revealed both CBS and insurance to be significant predictors for receiving PBT. A unit increase in CBS was associated with 1.04 times increased odds of receiving PBT (OR=1.04, 95%CI: 1.01-1.07, p=0.0145) and having Medicare was associated with 3.13 times increased odds of receiving PBT (OR=3.13, 95%CI: 1.57-6.26, p=0.0012). Subgroup analysis, which only included patients enrolled prior to opening the second gantry, showed 1.05 times increased odds of receiving PBT per unit increase in CBS (OR=1.05, 95%CI: 1.00-1.10, p=0.03) and 2.87 times increased odds of receiving PBT in patients with Medicare (OR=2.87, 95%CI: 1.04-7.92, p=0.04). Conclusion The CBS utilized was significantly associated with the receipt of PBT in a cost-neutral payer setting. Physicians may consider the use of CBS as a resource allocation tool.
Keywords: clinical score; proton therapy; radiation; radiotherapy; resource allocation.
Copyright © 2019, Sharma et al.
Conflict of interest statement
The authors have declared financial relationships, which are detailed in the next section.
Similar articles
-
Ethical Allocation of Proton Therapy and the Insurance Review Process.Pract Radiat Oncol. 2021 Sep-Oct;11(5):e449-e458. doi: 10.1016/j.prro.2021.01.007. Epub 2021 Feb 3. Pract Radiat Oncol. 2021. PMID: 33548544
-
Differences in Patterns of Care and Referral Between Proton and Photon Therapy.Int J Part Ther. 2024 Apr 22;11:100005. doi: 10.1016/j.ijpt.2023.10.001. eCollection 2024 Mar. Int J Part Ther. 2024. PMID: 38757072 Free PMC article.
-
Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea.Cancer Res Treat. 2021 Oct;53(4):935-943. doi: 10.4143/crt.2021.409. Epub 2021 May 17. Cancer Res Treat. 2021. PMID: 34015892 Free PMC article.
-
Proton beam therapy in rectal cancer: A systematic review and meta-analysis.Surg Oncol. 2021 Sep;38:101638. doi: 10.1016/j.suronc.2021.101638. Epub 2021 Jul 27. Surg Oncol. 2021. PMID: 34340196
-
Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.Clin Oncol (R Coll Radiol). 2022 Jun;34(6):e225-e237. doi: 10.1016/j.clon.2021.12.015. Epub 2022 Jan 15. Clin Oncol (R Coll Radiol). 2022. PMID: 35042622 Review.
Cited by
-
Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.JAMA Netw Open. 2022 Apr 1;5(4):e228970. doi: 10.1001/jamanetworkopen.2022.8970. JAMA Netw Open. 2022. PMID: 35471569 Free PMC article.
References
-
- Particle Therapy Co-Operative Group. Particle therapy facilities in clinical operation. [Apr;2019 ];https://www.ptcog.ch/index.php/facilities-in-operation 2019
-
- Proton beam therapy in pediatric oncology. Baliga S, Yock TI. Curr Opin Pediatr. 2019;31:28–34. - PubMed
-
- Proton therapy - a systemic review of clinical effectiveness. Olsen DR, Bruland OS, Frykholm G, Norderhaugd IN. Radiother Oncol. 2007;83:123–132. - PubMed
-
- Charged particles in radiotherapy: a 5-year update of a systemic review. De Ruysscher D, Mark Lodge M, Jones B, Bradad M, Munroe A, Jefferson T, Pijls-Johannesmaa M. Radiother Oncol. 2012;103:5–7. - PubMed
LinkOut - more resources
Full Text Sources